Modella AI and illumiSonics Announce Successful Research Compatibility Between Virtual H&E Imaging and Generative AI-Powered Pathology Diagnostic Platform

BOSTON & WATERLOO, Ontario — Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free optical imaging and computational pathology, today announced successful research demonstrating compatibility between illumiSonics’ research-use only Multi-Laser Imaging (MLI™) system and Modella AI’s research-use only PathChat™ DX platform…
Read More

About The Author

Jonathan Jeriah

See author's posts